Concepedia

Paul Y. Kwo

PY

Statistics

Publications

152

Citations

18.6K

H-Index

62

Active since

1992

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Stanford University

Stanford Medicine

Johns Hopkins University

Paul Y. Kwo is an author at Indiana University – Purdue University Indianapolis specializing in medicine, viral hepatitis, and antiviral therapy.

ORCID

Publications per year

1992–2025

152

Publications

152

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +17

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Paul Y. Kwo, Stanley M. Cohen, Joseph K. Lim · The American Journal of Gastroenterology · 2016 · 1.2K citations

, , +16

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Michael Charlton, Gregory T. Everson, Steven L. Flamm et al. · Gastroenterology · 2015 · 799 citations · Full text

, , +17

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski et al. · Gastroenterology · 2010 · 723 citations · Full text

, , +17

1–5 of 152